Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Title: Intravitreal Interventions – Volume 3, Number 3
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by educational grants from Genentech, Inc. and Regeneron Pharmaceuticals, Inc.
Target Audience: The intended audience for this activity is retina specialists and other health care professionals involved in the treatment of patients with retina disorders.
Learning Objectives:
At the conclusion of this publication series participants should be able to:
- Differentiate between the treatment options approved for use in diseases of the retina to facilitate the design of regimens that are optimized for the individual patient’s diagnosis, needs, values, and goals.
- Compare established treatment guidelines with emerging clinical data in order to effectively apply the available agents for treating retinal disease.
- Utilize integrated information sources that synthesize an overview of state-of-the-art retinal therapy based on both existing treatment standards and emerging research data.
- Review the technological advances in retinal imaging and the refinements in maintenance therapy that are emerging from long-term clinical studies, to ensure that follow-up treatment for patients with retinal disease is effective and appropriate.
- Assess the evidence addressing the controversies surrounding the safe administration of intravitreal medications.
- Apply the recommendations arising from established guidelines and recent research to the treatment of specific retinal disorders.
- Compare the clinical risks and benefits of pharmacologic vitreolysis and vitrectomy for the treatment of vitreomacular adhesion and macular hole.
Chief Medical Editor:
Carmen A. Puliafito, MD, MBA
Dean, Keck School of Medicine
Professor of Ophthalmology and Health Management
May S. and John Hooval Dean’s Chair in Medicine
University of Southern California
Los Angeles, CA
Contributing Faculty:
Diana V. Do, MD
Associate Professor of Ophthalmology
Vice Chair for Education
Director, Carl Camras Center for Innovative Clinical Trials in Ophthalmology
Director, Ophthalmology Residency Training Program
Stanley M. Truhlsen Eye Institute
University of Nebraska Medical Center
Omaha, NE
Harry W. Flynn, Jr., MD
Department of Ophthalmology
Bascom Palmer Eye Institute
University of Miami School of Medicine
Miami, FL
K. Bailey Freund, MD
Clinical Associate Professor
New York University School of Medicine
Vitreous Retina Macula Consultants of New York
New York, NY
John E. Legarreta, MD
Instructor of Ophthalmology
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine
Miami, FL
Quan Dong Nguyen, MD, MSc
McGaw Memorial Endowed Chair in Ophthalmology
Professor and Chairman of Ophthalmology
Director of the Stanley M. Truhlsen Eye Institute
University of Nebraska Medical Center
Omaha, NE
Philip J. Rosenfeld, MD, PhD
Professor of Ophthalmology
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine
Miami, FL
SriniVas R. Sadda, MD
Associate Professor of Ophthalmology
Keck School of Medicine
University of Southern California
Director, Doheny Image Reading Center
Doheny Eye Institute
Los Angeles, CA
Stephen G. Schwartz, MD, MBA
Associate Professor of Ophthalmology
University of Miami Miller School of Medicine
Miami, FL
Medical Director
Bascom Palmer Eye Institute at Naples
Naples, FL
Michael W. Stewart, MD
Professor and Chairman
Department of Ophthalmology
Mayo Clinic Florida
Jacksonville, FL
Reviewer:
Ronald Codario, MD, FACP, CCMEP
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, December 1, 2014, through December 1, 2015.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, read the articles, complete the CME posttest, and complete and return the registration form and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Planning Committee and Faculty members report the following relationship(s):
Carmen A. Puliafito, MD, MBA
Receipt of Intellectual Property Rights/Patent Holder: Carl Zeiss Meditec
Diana V. Do, MD
Consulting Fee: Allergan, Bayer Healthcare, Genentech, Inc., Regeneron Pharmaceuticals, Inc.
Consulting Fee (Spouse): Bausch + Lomb, Santen
Contracted Research: Genentech, Inc., Regeneron Pharmaceuticals, Inc.
Harry W. Flynn, Jr., MD
No relevant financial relationships to disclose.
K. Bailey Freund, MD
Consulting Fee: Bayer Healthcare, Genentech, Inc., Heidelberg Engineering, Regeneron Pharmaceuticals, Inc., ThromboGenics
Contracted Research: Allergan, Genentech, Inc.
John E. Legarreta, MD
No relevant financial relationships to disclose.
Quan Dong Nguyen, MD, MSc
Consulting Fee: Santen
Contracted Research: Genentech, pSivida, Regeneron, Santen, XOMA
Philip J. Rosenfeld, MD, PhD
Contracted Research: Carl Zeiss Meditec
SriniVas R. Sadda, MD
Consulting Fee: Carl Zeiss Meditec, Optos
Stephen G. Schwartz, MD, MBA
Consulting Fee: Alimera, Bausch + Lomb
Michael W. Stewart, MD
Consulting Fee: Boehringer Ingelheim
Advisory Board: Regeneron Pharmaceuticals, Inc.
Reviewer reports the following relationship(s):
Ronald Codario, MD, FACP, CCMEP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2014 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicomeded.com